Jinxin returns to the black on U.S. recovery, focus on high-end clients

Fertility services company Jinxin Fertility Group Ltd. (1951.HK) said on Tuesday it swung to profitability in the first half of this year from a loss a year earlier, as its U.S. business recovered and it sharpened its focus on VIP customers.
Jinxin said it expects to report a profit of 90 million yuan ($13.3 million) or more for the six months to June, reversing a 1.04 billion yuan loss a year earlier. It said it expects to report earnings before interest, taxes, deprecation and amortization (EBITDA) of 290 million yuan or more for the latest period, compared with an EBITDA loss of 938 million yuan a year earlier.
In addition to improvement in its U.S. operations and greater focus on VIP customers, the company also cited improvement in its China-based business for the profit improvement. It added its 2025 results were affected by impairment losses and other one-time items in the first half of that year, which were absent in the first half of 2026.
Jinxin’s stock is down about 30% over the last 52 weeks.
By Doug Young
To subscribe to Bamboo Works weekly free newsletter, click here